Gossamer Bio, Inc. (GOSS)
0.1762
+0.02
(+13.90%)
USD |
NASDAQ |
Aug 24, 16:00
0.1699
-0.01
(-3.58%)
After-Hours: 20:00
Gossamer Bio Total Assets (Quarterly) : 76.87M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.87M |
| March 31, 2026 | 128.90M |
| December 31, 2025 | 172.25M |
| September 30, 2025 | 208.82M |
| June 30, 2025 | 240.92M |
| March 31, 2025 | 280.59M |
| December 31, 2024 | 315.29M |
| September 30, 2024 | 350.88M |
| June 30, 2024 | 373.45M |
| March 31, 2024 | 259.36M |
| December 31, 2023 | 311.92M |
| September 30, 2023 | 347.92M |
| June 30, 2023 | 181.75M |
| March 31, 2023 | 219.91M |
| December 31, 2022 | 272.45M |
| September 30, 2022 | 323.54M |
| June 30, 2022 | 245.84M |
| March 31, 2022 | 294.68M |
| Date | Value |
|---|---|
| December 31, 2021 | 343.66M |
| September 30, 2021 | 387.04M |
| June 30, 2021 | 432.51M |
| March 31, 2021 | 482.47M |
| December 31, 2020 | 539.43M |
| September 30, 2020 | 584.18M |
| June 30, 2020 | 625.08M |
| March 31, 2020 | 371.48M |
| December 31, 2019 | 426.60M |
| September 30, 2019 | 469.75M |
| June 30, 2019 | 507.17M |
| March 31, 2019 | 515.95M |
| December 31, 2018 | 239.42M |
| September 30, 2018 | 262.18M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.445M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| United Therapeutics Corp. | 7.220B |
| Arbutus Biopharma Corp. | 274.02M |
| Kura Oncology, Inc. | 587.79M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 170.90M |
| Shareholders Equity (Quarterly) | -94.03M |
| Debt to Equity Ratio | -0.4261 |
| Current Ratio | 0.5278 |
| Net Debt Paydown Yield | 40.45% |